{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:41Z","timestamp":1786118981116,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12,1]]},"DOI":"10.1097\/qai.0b013e318189a780","type":"journal-article","created":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T03:11:21Z","timestamp":1226545881000},"page":"369-376","source":"Crossref","is-referenced-by-count":47,"title":["Antiretroviral Therapy Exposure and Insulin Resistance in the Women's Interagency HIV Study"],"prefix":"10.1097","volume":"49","author":[{"given":"Phyllis C","family":"Tien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mardge","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"DeHovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E","family":"Justman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210131","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"R2-4-20210131","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"R3-4-20210131","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1097\/00002030-199815000-00001","article-title":"Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.","volume":"12","author":"Walli","year":"1998","journal-title":"AIDS"},{"key":"R4-4-20210131","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/01.aids.0000181011.62385.91","article-title":"Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.","volume":"19","author":"Brown","year":"2005","journal-title":"AIDS"},{"key":"R5-4-20210131","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R6-4-20210131","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","article-title":"Coronary heart disease in HIV-infected individuals.","volume":"33","author":"Currier","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-4-20210131","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction.","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"R8-4-20210131","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00126334-200208150-00002","article-title":"Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?","volume":"30","author":"Klein","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"R9-4-20210131","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1097\/00002030-200304001-00010","article-title":"Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era.","volume":"17","author":"Vittecoq","year":"2003","journal-title":"AIDS"},{"key":"R10-4-20210131","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/CDLI.12.9.1013-1019.2005","article-title":"The Womens Interagency HIV Study: an observational cohort brings clinical sciences to the bench.","volume":"12","author":"Bacon","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"R11-4-20210131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001648-199803000-00004","article-title":"The Womens Interagency HIV Study. WIHS Collaborative Study Group.","volume":"9","author":"Barkan","year":"1998","journal-title":"Epidemiology"},{"key":"R12-4-20210131","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1097\/QAD.0b013e32827038d0","article-title":"Antiretroviral therapy exposure and incidence of diabetes mellitus in the Womens Interagency HIV Study.","volume":"21","author":"Tien","year":"2007","journal-title":"AIDS"},{"key":"R13-4-20210131","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"R14-4-20210131","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/aje\/kwg206","article-title":"Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.","volume":"158","author":"Cole","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R17-4-20210131","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1002\/sim.2836","article-title":"Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution.","volume":"26","author":"Cox","year":"2007","journal-title":"Stat Med"},{"key":"R18-4-20210131","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1086\/496981","article-title":"The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection.","volume":"41","author":"Lo","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R19-4-20210131","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/QAI.0b013e31804216cf","article-title":"Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strategy.","volume":"44","author":"Shlay","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R20-4-20210131","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/1568005054880163","article-title":"Insulin resistance in the HIV-infected population: the potential role of mitochondrial dysfunction.","volume":"5","author":"Shikuma","year":"2005","journal-title":"Curr Drug Targets Infect Disord"},{"key":"R21-4-20210131","doi-asserted-by":"crossref","first-page":"E1666","DOI":"10.1152\/ajpendo.00550.2006","article-title":"Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults.","volume":"292","author":"Fleischman","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R22-4-20210131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000182230.47819.aa","article-title":"Fat distribution in men with HIV infection.","volume":"40","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-4-20210131","first-page":"562","article-title":"J Acquir Immune Defic Syndr.","volume":"42","year":"2006","journal-title":""},{"key":"R24-4-20210131","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.288.2.207","article-title":"Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.","volume":"288","author":"Carr","year":"2002","journal-title":"JAMA"},{"key":"R25-4-20210131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00126334-200305010-00005","article-title":"Randomized, controlled, 48-week study of switching stavudine and\/or protease inhibitors to combivir\/abacavir to prevent or reverse lipoatrophy in HIV-infected patients.","volume":"33","author":"John","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R26-4-20210131","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","article-title":"Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.","volume":"14","author":"Mallal","year":"2000","journal-title":"AIDS"},{"key":"R27-4-20210131","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"},{"key":"R28-4-20210131","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/ajcn\/76.2.460","article-title":"Body-composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men.","volume":"76","author":"Meininger","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"R29-4-20210131","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00126334-200012010-00004","article-title":"Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.","volume":"25","author":"Mynarcik","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-4-20210131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.qai.0000248353.56125.43","article-title":"Relation of stavudine discontinuation to anthropometric changes among HIV-infected women.","volume":"44","author":"Tien","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R31-4-20210131","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00042560-200106010-00006","article-title":"Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients.","volume":"27","author":"Dube","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R32-4-20210131","doi-asserted-by":"crossref","first-page":"837","DOI":"10.7326\/0003-4819-129-10-199811150-00022","article-title":"Impaired glucose tolerance and protease inhibitors.","volume":"129","author":"Walli","year":"1998","journal-title":"Ann Intern Med"},{"key":"R33-4-20210131","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200203290-00002","article-title":"Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study.","volume":"16","author":"Noor","year":"2002","journal-title":"AIDS"},{"key":"R34-4-20210131","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00002030-200403050-00008","article-title":"The metabolic effects of lopinavir\/ritonavir in HIV-negative men.","volume":"18","author":"Lee","year":"2004","journal-title":"AIDS"},{"key":"R35-4-20210131","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","article-title":"Metabolic effects of indinavir in healthy HIV-seronegative men.","volume":"15","author":"Noor","year":"2001","journal-title":"AIDS"},{"key":"R36-4-20210131","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2337\/diacare.27.2.354","article-title":"Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Womens Health Across the Nation (SWAN).","volume":"27","author":"Torrens","year":"2004","journal-title":"Diabetes Care"},{"key":"R37-4-20210131","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance.","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"R38-4-20210131","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.23.1.57","article-title":"Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.","volume":"23","author":"Bonora","year":"2000","journal-title":"Diabetes Care"},{"key":"R39-4-20210131","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/oxfordjournals.aje.a010187","article-title":"Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.","volume":"151","author":"Hanson","year":"2000","journal-title":"Am J Epidemiol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e318189a780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:13:35Z","timestamp":1786036415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200812010-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,1]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318189a780","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12,1]]}}}